Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary
- Dean F. Bajorin
- , J. Alfred Witjes
- , Jürgen E. Gschwend
- , Michael Schenker
- , Begoña P. Valderrama
- , Yoshihiko Tomita
- , Aristotelis Bamias
- , Thierry Lebret
- , Shahrokh F. Shariat
- , Se Hoon Park
- , Dingwei Ye
- , Mads Agerbaek
- , Deborah Enting
- , Ray McDermott
- , Pablo Gajate
- , Avivit Peer
- , Matthew I. Milowsky
- , Alexander Nosov
- , João Neif Antonio
- , Krzysztof Tupikowski
- Weill Cornell Medical College
- Radboud University Nijmegen
- Nectarie Oncology Center
- Hospital Universitario Virgen del Rocío
- Niigata University Graduate School of Medical and Dental Sciences
- University of Athens
- Versailles Saint Quentin University
- Weill Cornell Medicine
- Allgemeines Krankenhaus
- UT Southwestern Medical Center
- Charles University
- I.M. Sechenov First Moscow State Medical University
- Samsung Medical Center, Sungkyunkwan University
- Fudan University Shanghai Cancer Center
- Aarhus University Hospital
- Guy's and St. Thomas' National Health Service Foundation Trust
- St Vincent's University Hospital
- Neurología)
- Rambam Medical Center
- University of North Carolina
- Ministry of Health of the Russian Federation
- Barretos Cancer Hospital
- Wroclaw Comprehensive Cancer Center
- Biocon Bristol-Myers Squibb Research Centre
- Mount Sinai School of Medicine
Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel › Begutachtung
2
Zitate
(Scopus)